Additionally, CRH was decreased in SAA+ Lewy body disease compared with SAA− Alzheimer’s disease/frontotemporal dementia/vascular dementia (with an overlap between groups). This evidence concerns the gene CRH and early-onset autosomal dominant Alzheimer disease.